Robbins LLP is encouraging BIIB investors who have experienced significant losses to reach out to the firm to learn more about the class action lawsuit involving Biogen Inc.

Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons and entities that purchased or otherwise acquired Biogen Inc. (NASDAQ: BIIB) securities between February 3…

Read More: https://www.businesswire.com/news/home/20240603116776/en/